Relay Therapeutics Inc (RLAY) Hedge Fund Ownership (Q2 2026)

Relay Therapeutics Inc (RLAY)

255 + Investors. Track Smart Money conviction in RLAY. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — RLAY

Based on 260 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added RLAY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

260 hedge funds hold RLAY right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +28% more funds vs a year ago

fund count last 6Q

+57 new funds entered over the past year (+28% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 62% buying

169 buying103 selling

Last quarter: 169 funds were net buyers (56 opened a brand new position + 113 added to an existing one). Only 103 were sellers (65 trimmed + 38 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~56 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 22 → 51 → 51 → 56. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

44% of holders stayed for 2+ years

■ 44% conviction (2yr+) ■ 28% medium ■ 27% new

115 out of 260 hedge funds have held RLAY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +151% but shares only +33% — price-driven

Value

+151%

+32%

Last quarter: the total dollar value of institutional holdings rose +151%, but actual share count only changed +33%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

33 → 22 → 51 → 51 → 56 new funds/Q

New funds entering each quarter: 22 → 51 → 51 → 56. A growing number of institutions are discovering RLAY each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 54% veterans vs 30% newcomers

■ 54% veterans ■ 15% 1-2yr ■ 30% new

Entry-cohort mix of 267 holders: 145 (54%) are 2+ year veterans, 41 entered 1–2 years ago, and 81 (30%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 39% AUM from major funds

39% from top-100 AUM funds

50 of 258 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.1

out of 10

Moderate Exit Risk

Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	255	242	5.37%
13F Shares	249M	190M	31.0%
Total Value	$4.41B	$1.83B	141.69%
New Positions	55	51	+4
Increased Positions	113	91	+22
Closed Positions	40	32	+8
Reduced Positions	62	54	+8
Total Calls	4	3	33.33%
Total Puts	5	2	150.0%
PUT/CALL Ratio	1.25	0.67	Bearish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

255

242

5.37%

13F Shares

249M

190M

31.0%

Total Value

$4.41B

$1.83B

141.69%

New Positions

Increased Positions

113

+22

Closed Positions

Reduced Positions

Total Calls

33.33%

Total Puts

150.0%

PUT/CALL Ratio

1.25

0.67

Bearish

Institutional Holders (2026 Q2)

255 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RLAY. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 RLAY holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Casdin Capital, LLC	15.02%	16,035,240	$300.0M
2	Commodore Capital LP	13.37%	12,000,000	$224.5M
3	Spruce Street Capital LP	10.95%	2,984,125	$55.8M
4	Foresite Capital Management IV, LLC	8.06%	1,250,000	$23.4M
5	Elmind Capital, LP	6.89%	1,465,279	$27.4M
6	Sb Investment Advisers (uk) Ltd	6.81%	27,904,963	$522.1M
7	Nextech Invest Ltd.	6.02%	6,776,506	$126.8M
8	Squadron Capital Management LLC	5.63%	970,000	$18.1M
9	Perceptive Advisors LLC	3.96%	14,106,187	$263.9M
10	Kynam Capital Management, LP	3.41%	3,300,000	$61.7M
11	Timothy G. Youngquist 2020 Irrevocable Trust	3.09%	499,058	$4.2M
12	MPM BioImpact LLC	2.76%	2,415,672	$45.2M
13	Bellevue Group AG	2.44%	6,185,970	$115.7M
14	HighVista Strategies LLC	2.16%	506,235	$9.5M
15	TCG Crossover Management, LLC	1.92%	4,273,356	$80.0M
16	Tetragon Partners GP Ltd	1.68%	570,311	$10.7M
17	Siren, L.L.C.	1.38%	3,650,000	$68.3M
18	Rhenman & Partners Asset Management AB	1.00%	566,000	$10.6M
19	Affinity Asset Advisors, LLC	0.89%	1,050,000	$19.6M
20	EcoR1 Capital, LLC	0.63%	697,948	$13.1M
21	Boxer Capital Management, LLC	0.63%	450,000	$8.4M
22	Sphera Funds Management LTD.	0.57%	233,836	$4.4M
23	Seven Fleet Capital Management LP	0.55%	178,222	$3.3M
24	Exome Asset Management LLC	0.55%	47,531	$889K
25	Diadema Partners LP	0.55%	230,677	$4.3M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Relay Therapeutics Inc (RLAY)

What does the Smart Money Trend signal show for RLAY?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added RLAY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RLAY?

More buyers than sellers — 62% buying: Last quarter: 169 funds were net buyers (56 opened a brand new position + 113 added to an existing one). Only 103 were sellers (65 trimmed + 38 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for RLAY holders?

Strong quality — 39% AUM from major funds: 50 of 258 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held RLAY?

44% of holders stayed for 2+ years: 115 out of 260 hedge funds have held RLAY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Relay Therapeutics Inc (RLAY)

Smart Money Signals — RLAY

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +28% more funds vs a year ago

More buyers than sellers — 62% buying

Steady new buyers — ~56 new funds per quarter

44% of holders stayed for 2+ years

Value +151% but shares only +33% — price-driven

Growing discovery — still being found

Veteran-anchored — 54% veterans vs 30% newcomers

Strong quality — 39% AUM from major funds

Institutional Sentiment Summary — RLAY

Hedge Fund Ownership: RLAY

Market Analysis: RLAY

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: RLAY

Hedge Fund Positioning: RLAY

Statistics: RLAY

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Relay Therapeutics Inc (RLAY)

Welcome to 13Foresight!